Inspire Medical Systems, Inc. (INSP) Operating Margin
- Operating margin · 12 months: Value 6.02%; Formula and calculation Operating income / revenue. Period ending 2026-06-30..
Operating margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | 6.02% | Operating income / revenue. Period ending 2026-06-30. $54.12M ÷ $898.74M × 100 ≈ 6.02% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | 54.12M USD | Operating Income (Loss) |
| Revenue | 898.74M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 124.64M USD | Cost of Goods and Services Sold |
| Research and development | 99.68M USD | Research and Development Expense |
| Selling, general and administration | 620.30M USD | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2026-06-30 | $54.12M | $898.74M | $124.64M | $99.68M | $620.30M | 6.02% |
| 2026-03-31 | $51.32M | $915.25M | $130.19M | $101.19M | $632.55M | 5.61% |
| 2025-12-31 | $50.95M | $911.98M | $133.22M | $103.17M | $624.64M | 5.59% |
| 2025-09-30 | $36.73M | $882.62M | $133.14M | $108.56M | $604.19M | 4.16% |
| 2025-06-30 | $41.40M | $861.31M | $133.77M | $110.43M | $575.71M | 4.81% |
| 2025-03-31 | $49.82M | $840.11M | $128.94M | $113.08M | $548.28M | 5.93% |
| 2024-12-31 | $36.08M | $802.80M | $122.99M | $114.13M | $529.61M | 4.49% |
| 2024-09-30 | $13.50M | $755.59M | $115.05M | $114.84M | (m) | 1.79% |
| 2024-06-30 | $-14.29M | $705.71M | $107.04M | $117.91M | (m) | -2.03% |
| 2024-03-31 | $-35.99M | $660.91M | $101.44M | $119.87M | (m) | -5.45% |
| 2023-12-31 | $-40.27M | $624.80M | $96.58M | $116.54M | $451.96M | -6.45% |
| 2023-09-30 | $-49.90M | $570.19M | $90.67M | $106.73M | (m) | -8.75% |
| 2023-06-30 | $-53.63M | $526.08M | $86.08M | $98.58M | (m) | -10.19% |
| 2023-03-31 | $-51.03M | $466.37M | $76.00M | $82.29M | (m) | -10.94% |
| 2022-12-31 | $-47.59M | $407.86M | $66.11M | $68.64M | $320.69M | -11.67% |
| 2022-09-30 | $-49.08M | $348.35M | $55.12M | $57.69M | (m) | -14.09% |
| 2022-06-30 | $-41.68M | $300.85M | $43.96M | $46.31M | (m) | -13.85% |
| 2022-03-31 | $-40.22M | $262.42M | $37.30M | $41.07M | (m) | -15.33% |
| 2021-12-31 | $-39.85M | $233.39M | $33.28M | $37.35M | $202.62M | -17.07% |
| 2021-09-30 | $-45.09M | $201.00M | $29.28M | $34.34M | (m) | -22.43% |
| 2021-06-30 | $-45.19M | $175.16M | $25.87M | $32.03M | (m) | -25.80% |
| 2021-03-31 | $-55.46M | $134.39M | $20.31M | $28.81M | (m) | -41.27% |
| 2020-12-31 | $-56.21M | $115.38M | $17.62M | $26.09M | $127.87M | -48.72% |
| 2020-09-30 | $-58.44M | $96.28M | (m) | $22.57M | (m) | -60.70% |
| 2020-06-30 | $-57.20M | $81.30M | (m) | $18.89M | (m) | -70.36% |
| 2020-03-31 | $-42.56M | $87.15M | (m) | $15.67M | (m) | -48.84% |
| 2019-12-31 | $-34.90M | $82.05M | (m) | $12.84M | $90.47M | -42.53% |
| 2019-09-30 | $-30.50M | $71.70M | (m) | $11.22M | (m) | -42.54% |
| 2019-06-30 | $-26.50M | $63.90M | (m) | $9.37M | (m) | -41.47% |
| 2019-03-31 | $-23.96M | $56.80M | (m) | $8.26M | (m) | -42.18% |
| 2018-12-31 | $-20.38M | $50.59M | (m) | $7.39M | $53.53M | -40.28% |
| 2018-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $-16.00M | $28.57M | (m) | $6.19M | $32.36M | -56.02% |
| 2017-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $-17.25M | $16.43M | (m) | $7.09M | $22.68M | -105.03% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |